KR20040035336A - A concentration-liquid production method and food by using of the deer-meat and deer-bone - Google Patents
A concentration-liquid production method and food by using of the deer-meat and deer-bone Download PDFInfo
- Publication number
- KR20040035336A KR20040035336A KR1020020064443A KR20020064443A KR20040035336A KR 20040035336 A KR20040035336 A KR 20040035336A KR 1020020064443 A KR1020020064443 A KR 1020020064443A KR 20020064443 A KR20020064443 A KR 20020064443A KR 20040035336 A KR20040035336 A KR 20040035336A
- Authority
- KR
- South Korea
- Prior art keywords
- deer
- bone
- sample
- ganglioside
- meat
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 4
- 235000013305 food Nutrition 0.000 title claims description 14
- 241001492697 Centropogon cornutus Species 0.000 title claims description 12
- 239000007788 liquid Substances 0.000 title abstract 3
- 150000002270 gangliosides Chemical class 0.000 claims abstract description 28
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 26
- 241000282994 Cervidae Species 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000012153 distilled water Substances 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 238000011088 calibration curve Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012468 concentrated sample Substances 0.000 claims description 2
- 238000011161 development Methods 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000012086 standard solution Substances 0.000 claims description 2
- 239000012520 frozen sample Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 210000003056 antler Anatomy 0.000 abstract description 17
- 239000000284 extract Substances 0.000 abstract description 12
- 239000008187 granular material Substances 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 239000007903 gelatin capsule Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 241000283011 Rangifer Species 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/30—Meat extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Abstract
Description
본 발명은 사슴뼈에서 갱글리오사이드(Ganglioside)를 추출하여 이를 농축액으로 제조함과 함께 사슴육(및 사슴뼈)에서도 갱글로사이드를 추출하여 이를 분말로 제조하여 식품으로 사용할 수 있도록 한 사슴육과 뼈를 이용한 농축액 제조방법 및 이를 이용한 식품에 관한 것이다.The present invention extracts the ganglioside (Ganglioside) from the stag bone and produce it as a concentrate, and extract the gangloside from the deer meat (and stag bone) to make it as a powder to be used as food foods and bones It relates to a method for producing a concentrate using and foods using the same.
일반적으로 사슴의 효용가치는 대표적인 건강식품 소재인 녹용으로 사용되는 경우가 대부분이며, 사슴육이 일부 이용되고 있으나 뼈 및 부산물을 이용한 제품의 개발이 전무하여 이를 이용한 새로운 고부가 가치성 제품의 개발이 필요한 실정이다.In general, the utility value of deer is mostly used as antler, which is a representative health food material, and deer meat is partially used, but there is no development of products using bones and by-products. to be.
통상, 녹용은 숫사슴의 갓 자란 뿔을 채취 가공하여 건조한 것을 말하며, 사슴은 매년 3월 중순경부터 늙은 뿔이 떨어지고, 새뿔이 돋아나기 시작하는데 이때 골질화 되지 않은 어린뿔(幼角)을 녹용이라 한다.Normally, antlers are freshly grown horns of bucks and processed and dried. Deer antlers start to drop off old horns and sprout new horns from mid-March each year. This is called.
녹용은 산지 및 사슴의 종류에 따라 마록, 매화록, 시베리아산 대록, 뉴질랜드산 직록, 순록 등으로 구분할 수 있으며 한방에서는 최고의 보혈강장제로 널리 사용되어 온 고귀한 생약재이다.Deer antler can be divided into manok, plum, siberian, and new zealand, and reindeer according to the mountain and deer. It is a noble herbal medicine widely used as the best blood tonic in oriental medicine.
최근, 녹용을 이용한 동물실험 및 임상실험결과, 소아의 성장 발육촉진 효과, 노화억제 효과, 조혈기능 효과, 심장기능 개선 효과, 항근육피로 효과 및 항진통 효과 등이 있는 것으로 밝혀졌다.Recently, animal experiments and clinical trials using deer antler have been found to have growth-promoting effects, aging inhibitory effects, hematopoietic function, heart function improvement, anti-muscular fatigue effect and anti- analgesic effect in children.
이 녹용중의 노화억제 성분의 하나로서 알려져 있는, 핵산 대사산물의 일종인 하이포크산틴(Hypoxanthine)은 동물 실험결과, 노화가 진행됨에 따라 그 활성이 증가하는 모노아민옥시다제(MonoamineoxidaseB)의 활성을 저해함으로써 노화억제 작용을 하는 것으로 알려져 있다.Hypoxanthine, a kind of nucleic acid metabolite known to be one of the aging inhibitors in antler, inhibits the activity of monoamineoxidase B, whose activity increases with aging as a result of animal experiments. It is known to act to inhibit aging.
또한, 녹용의 지용성 성분중 당지질의 일종인 갱글리오사이드(Ganglioside)는 신장, 간, 지라, 뇌의 회백질에 축적되어 있는 고분자의 당지질로서 임상실험 결과 신경세포의 전달장애에 관련된 당뇨병 및 신경독증에 유효한 것으로 알려져 있다.In addition, Ganglioside, a type of glycolipid among the fat-soluble components of antler, is a glycolipid of polymers accumulated in the gray matter of kidney, liver, spleen, and brain. It is known to be valid.
상기와 같은 동물 및 임상실험 결과에서 알 수 있듯이, 녹용은 인체에 유효한 각종 성분을 다량 함유하고 있는 보약 및 치료제로서의 가치가 높은 동물 생약재이며, 갱글리오사이드라는 물질이 포함되어 있어 건강식품을 원하는 많은 사람들이 녹용을 구하고 있으나 이러한 녹용을 공급하는데 한계가 있으며 녹용이 비싸기 때문에 일반인들에게 널리 공급되지 못하고 있는 실정이다.As can be seen from the above animal and clinical test results, antler is an animal herbal medicine of high value as a medicine and a therapeutic agent containing a large amount of various ingredients effective for the human body, and contains a substance called gangliosides, and thus many people wanting health food. People are seeking antler, but there is a limit in supplying such antler and the antler is expensive and is not widely supplied to the general public.
상기 갱글리오사이드는 모유의 감염 방어인자로 인식되어 우유제품회사에서이러한 갱글리오사이드를 사용한 우유를 생산하고 있다.The gangliosides have been recognized as a defense against infection of breast milk and milk products using such gangliosides have been produced by milk product companies.
그러나 상기와 같은 사슴의 뿔에 포함되어 있는 갱글리오사이드는 통상적으로 사슴의 뿔에만 포함되어 있는 것으로 인식되어 있어 일반인들에게 있어서는 고가의 사슴뿔을 구하기가 힘들므로 널리 보급되지 못하고 있는 실정이다.However, the gangliosides included in the deer's horns are generally recognized to be included only in the deer's horns, so it is difficult to obtain expensive antlers for the general public, and thus they are not widely used.
본 발명은 상기와 같은 종래의 문제점들을 해결하기 위한 것으로, 본 발명의 목적은, 상기한 종래 기술 또는 통상적인 기술의 결점을 개선하기 위하여 장기간의 연구 결과 단시간 내에 사슴육과 뼈로부터 갱글리오사이드를 추출하여 사슴뼈에서 나오는 갱글리오사이드로는 농축액을 제조하고, 사슴육(및 사슴뼈)에서 나오는 갱글리오사이드로는 분말을 제조하여 식품으로 사용할 수 있도록 하는 사슴육과 뼈를 이용한 농축액 제조방법 및 이를 이용한 식품을 제공하는데 있다.The present invention is to solve the above conventional problems, the object of the present invention, in order to improve the drawbacks of the above-described conventional or conventional techniques, extract ganglioside from deer meat and bone in a short time as a result of long-term research The gangliosides from the deer bone to produce a concentrate, and the gangliosides from the deer meat (and stag bone) to produce a powder to be used as food to produce a concentrate using deer meat and bone and To provide food.
즉, 본 발명은 녹용에만 포함되어 있는 것으로 인식된 갱글리오사이드를 녹용에서 추출하는 것이 아니라, 사슴육이나 뼈에서 추출하여 이를 식품으로 개발하여 일반인들에게 제공할 수 있도록 하는 사슴육과 뼈의 엑기스를 이용한 식품을 제공하는데 있다.That is, the present invention does not extract the gangliosides recognized as contained only in the antler, but extracts from the deer antler or bone and extracts from the deer meat or bone to develop them as food and provide them to the public. To provide used food.
이하, 본 발명의 실시 예를 첨부도면을 참고로 하여 상세히 설명하면 다음과 같다.Hereinafter, an embodiment of the present invention will be described in detail with reference to the accompanying drawings.
녹용은 보양, 간장의 대표적인 생약이며, 갱글리오사이드는 이러한 녹용품질의 지표적인 물질로 그 함량과 품질과 높은 상관성이 있는 것으로 알려져 있다.Deer antler is a representative herbal medicine of rejuvenation and soy sauce, and ganglioside is an indicator of such antler quality and is known to have a high correlation with its content.
육류를 이용한 전통적인 탕류는 우리 나라의 고유한 식속으로 새로운 외식산업으로 잠재성이 있어 충분한 관심의 대상이 될 수 있다.Traditional soups made with meat have the potential to serve as a new foodservice industry in our country's unique diet, which can be a subject of considerable interest.
검액의 조제는 사슴육과 뼈를 부위별로 나누어 분쇄하여 5g을 채취하여 200 ml의 폴치(folch)(CHC??3: MeOH = 2:1)용액을 가하고 균질화(10분, 2회)한 후 분액 깔대기에 여과시키고 용매에 대하여 20%(40 ml)의 증류수를 가하고 흔든 후 장시간 층분리를 시킨다.Prepare the sample solution by dividing the deer meat and bone into parts and crushing 5g, add 200 ml of folch (CHC ?? 3 : MeOH = 2: 1) solution, homogenize (10 minutes, 2 times) Filter into a funnel, add 20% (40 ml) of distilled water to the solvent, shake, and separate the layers for a long time.
또한, 층분리 후 하층의 여액을 받아서 40℃의 진공 증발기(vacuum evaporator)에서 농축시켜 최소량의 용매를 가하여 농축된 시료를 용해시키고, 10ml로 정량하여 냉동 보관하면서 시료로 사용한다.Further, after separating the layers, the lower layer was collected and concentrated in a vacuum evaporator at 40 ° C., a minimum amount of solvent was added to dissolve the concentrated sample.
한편, 표준액 및 시료 각각을 리노메트(LINOMAT)를 이용하여 10 μl씩 키에젤겔(Kieselgel)60F254HPTLC-플레이트(10 cm×10 cm)에 점적하여 전개용매(CHCl3 : MeOH : Water = 65 : 25 : 4)로 포화된 챔버(chamber)내 점적한 플레이트(plate)를 넣어 전개시키고, 용매를 휘발시켜 10% 황산(sulfuric acid)으로 발색하며, 105℃ 오븐(oven)에서 20분 정도 가열하여 HPTLC 스캐너(Scanner)를 이용하여 분석한다.Meanwhile, 10 μl of the standard solution and each sample were added to Kieselgel 60F 254 HPTLC-plate (10 cm × 10 cm) using LINOMAT to develop a developing solvent (CHCl 3: MeOH: Water = 65: 25: 4) developed by inserting a plate in a saturated chamber (chamber), evaporating the solvent to develop 10% sulfuric acid, heated in a 105 ℃ oven (20 minutes) Analyze using HPTLC Scanner.
또한, 갱글리오사이드(ganglioside)류의 표준품에 MeOH를 가하여 용해시킨 후 HPTLC법에 준하여 실험한 후 TLC 스캐너(scanner)로 파장 360nm에서 스캐닝하여 얻은 Rf 0.42 및 0.44의 피크면적으로부터 표준품의 검량선을 작성한다.In addition, a standard calibration curve was prepared from peak areas of Rf 0.42 and 0.44 obtained by dissolving MeOH in ganglioside standard by dissolving MeOH and performing experiment according to HPTLC method and scanning at wavelength of 360 nm with TLC scanner. do.
한편, 각 시료의 검액을 MeOH를 가하여 용해시키고, HPTLC법에 준하여 실험한 후 TLC 스캐너로 파장 360nm에서 스캐닝하여 얻은 Rf 0.42 및 0.44의 피크면적으로부터 시료중의 갱글리오사이드를 정량한다.On the other hand, the sample solution of each sample was dissolved by adding MeOH, tested according to the HPTLC method, and ganglioside in the sample was quantified from the peak areas of Rf 0.42 and 0.44 obtained by scanning at a wavelength of 360 nm with a TLC scanner.
소의 뇌에서 분리한 갱글리오사이드 표준품 중에서 Rf 0.42 및 Rf 0.44를 나타내는 갱글리오사이드를 표준품으로 하여 TLC 스캐너를 이용하여 각 표준품을 2mg/ml의 영역에서 검량선을 작성한 결과 검량선은 Rf 0.42의 경우 y=957.7x+162.5(r=0.9952), Rf 0.44의 경우 y=1173.4x+276.4Of the ganglioside standards isolated from bovine brains, gangliosides representing Rf 0.42 and Rf 0.44 were used as standard products, and calibration curves were prepared in the area of 2 mg / ml using a TLC scanner. 957.7x + 162.5 (r = 0.9952), y = 1173.4x + 276.4 for Rf 0.44
(r=0.9952)이다.(r = 0.9952).
시료를 분석한 경우 모든 시료에서 정량이 가능하며, 정량 결과는 다음의 표 1과 같다.When the sample is analyzed, quantification is possible in all samples, and the quantitative results are shown in Table 1 below.
본 발명은 상술한 바와 같이, 사슴뼈와 사슴육으로부터 갱글리오사이드를 추출하여 사슴뼈에서 나오는 갱글리오사이드로는 농축액으로 제조하여 식품으로 활용할 수 있도록 하고, 사슴육(및 사슴뼈)에서 나오는 갱글리오사이드로는 분말로 제조하여 식품으로 활용할 수 있도록 한다.The present invention, as described above, extract the ganglioside from the stag bone and stag meat, so that the ganglioside from the stag bone can be prepared as a concentrate and used as food, and the gangle from stag meat (and stag bone) Rioside furnace is made of powder so that it can be used as food.
즉, 상기 농축액으로 제조한 경우에는 휴대하고 다니면서 간편하게 먹을 수 있는 것이고, 상기 분말로 제조한 경우에는 이러한 원액 분말을 식품 등에 함께 넣어 먹을 수 있는 것이다.In other words, when prepared with the concentrate can be easily carried while carrying, and when prepared with the powder can be eaten together with the stock solution such as food.
상기 건강식품의 제조의 형태는 연질캡슐, 경질캡슐, 과립, 정제, 환제제 및 음료 제품일 수 있다.The form of preparation of the health food may be soft capsules, hard capsules, granules, tablets, pills and beverage products.
이상에서 상세히 설명한 바와 같은 본 발명은 사슴의 뼈와 고기에서 갱글리오사이드를 추출하여 이를 농축액이나 분말로 제조함으로써 종래 사슴의 뿔에만 포함되어 있던 것으로 인식된 갱글리오사이드를 사슴뼈와 사슴육에서도 추출하여 가공한 후 일반인에게 용이하게 식용할 수 있도록 식품으로 제공할 수 있는 효과가 있다.The present invention as described in detail above extracts gangliosides from deer bones and venison and extracts gangliosides, which were previously recognized to be included only in the deer's horns, by extracting gangliosides from deer bones and meat. After processing, there is an effect that can be provided as a food to be easily edible to the public.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020064443A KR20040035336A (en) | 2002-10-22 | 2002-10-22 | A concentration-liquid production method and food by using of the deer-meat and deer-bone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020064443A KR20040035336A (en) | 2002-10-22 | 2002-10-22 | A concentration-liquid production method and food by using of the deer-meat and deer-bone |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040035336A true KR20040035336A (en) | 2004-04-29 |
Family
ID=37334282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020064443A KR20040035336A (en) | 2002-10-22 | 2002-10-22 | A concentration-liquid production method and food by using of the deer-meat and deer-bone |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040035336A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100778937B1 (en) * | 2006-09-25 | 2007-12-11 | 대상 주식회사 | Manufacturing method for concentration liquid of pig bone |
CN103141841A (en) * | 2013-03-14 | 2013-06-12 | 吉林省中韩动物科学研究院 | Method for preparing memory improvement product with cartialgenous |
KR101429568B1 (en) * | 2012-11-01 | 2014-09-23 | 주식회사농심 | Method of preparing deer bone extract having increased amount of ganglioside |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950010775A (en) * | 1993-10-22 | 1995-05-15 | 김정순 | Manufacturing method and composition of granulated sugar containing calcium and vitamin |
JPH0965854A (en) * | 1995-08-29 | 1997-03-11 | Life Service Kk | Health food containing deer material, its production and production of deer material |
KR20010009013A (en) * | 1999-07-06 | 2001-02-05 | 김영식 | A manufacturing method for a health food having venison as a vital element |
KR20030033099A (en) * | 2001-10-19 | 2003-04-30 | 조연근 | Nutrition food composition |
KR101107669B1 (en) * | 2007-03-19 | 2012-01-25 | 알프스 덴키 가부시키가이샤 | Phosphate-based inorganic material |
-
2002
- 2002-10-22 KR KR1020020064443A patent/KR20040035336A/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950010775A (en) * | 1993-10-22 | 1995-05-15 | 김정순 | Manufacturing method and composition of granulated sugar containing calcium and vitamin |
JPH0965854A (en) * | 1995-08-29 | 1997-03-11 | Life Service Kk | Health food containing deer material, its production and production of deer material |
KR20010009013A (en) * | 1999-07-06 | 2001-02-05 | 김영식 | A manufacturing method for a health food having venison as a vital element |
KR20030033099A (en) * | 2001-10-19 | 2003-04-30 | 조연근 | Nutrition food composition |
KR101107669B1 (en) * | 2007-03-19 | 2012-01-25 | 알프스 덴키 가부시키가이샤 | Phosphate-based inorganic material |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100778937B1 (en) * | 2006-09-25 | 2007-12-11 | 대상 주식회사 | Manufacturing method for concentration liquid of pig bone |
KR101429568B1 (en) * | 2012-11-01 | 2014-09-23 | 주식회사농심 | Method of preparing deer bone extract having increased amount of ganglioside |
CN103141841A (en) * | 2013-03-14 | 2013-06-12 | 吉林省中韩动物科学研究院 | Method for preparing memory improvement product with cartialgenous |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aune et al. | Comparison of oral and intraperitoneal toxicity of yessotoxin towards mice | |
Alyaqoubi et al. | Study of antioxidant activity and physicochemical properties of coconut milk (Pati santan) in Malaysia | |
Bitsch et al. | Bioavailability of antioxidative compounds from Brettacher apple juice in humans | |
Okunowo et al. | Nutritional value of Rhynchophorus phoenicis (F.) larvae, an edible insect in Nigeria | |
Rutqvist et al. | Spontaneous occurrence of ochratoxin residues in kidneys of fattening pigs | |
Liu et al. | Evaluation of the quality and flavor of salted duck eggs with partial replacement of NaCl by non-sodium metal salts | |
KR20040035336A (en) | A concentration-liquid production method and food by using of the deer-meat and deer-bone | |
CN106722797A (en) | Flavor chilli sauce | |
Jridi et al. | Vine (Vitis vinifera L.) leaves as a functional ingredient in pistachio calisson formulations | |
Muszyńska et al. | Impact of food processing on non-hallucinogenic indole derivatives in edible mushrooms | |
Lin et al. | Bioaccessibility in daily diet and bioavailability in vitro of aflatoxins from maize after cooking | |
CN106474160A (en) | A kind of method of fishy smell material and sex hormone in removal oviductus ranae | |
CN113439849B (en) | A marine fish peptide containing rhizoma Alpiniae Officinarum and its preparation method | |
CN112715935B (en) | Pilose antler buccal tablet and preparation method thereof | |
RU2651026C2 (en) | Method of processing of deer antlers | |
CN114948813A (en) | Anti-saccharification and anti-aging natural product composition, preparation method thereof and application thereof in oral beauty products | |
JP2002038183A (en) | Method for producing sphingoglycolipid-containing substance | |
Kenenbay et al. | Nutritive, chemical, and technological properties of liver paté formulated with beef offal, sheep tail fat and liquorice, and ginger root. | |
JPH09187226A (en) | Protein composition derived from sesame seed and its use | |
Peraica et al. | Mycotoxic and aristolochic acid theories of the development of endemic nephropathy | |
Karnila | Bioactive components of meat powder and viscera-gonad Holothuria scabra from Terung Island Waters, Batam, Indonesia | |
JP2008136435A (en) | Method for producing fermented soybean paste processed product, fermented soybean paste processed product, fermented soybean paste extracted solution, fermented soybean paste extraction deodorant, and fermented soybean paste extraction meat softening agent | |
Dadhaniya et al. | TOXICOLOGICAL STUDIES OF MONOSODIUM GLUTAMATE-A FOOD ADDITIVE. | |
KR102611995B1 (en) | Alcoholic beverage for meat containing soy sauce | |
JP2019077655A (en) | Food composition for improving lipid metabolism or suppressing hepatic lipid accumulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |